Navigation Links
New guidelines developed for improved DVT diagnosis
Date:2/14/2012

A researcher at Intermountain Medical Center in Salt Lake City is part of a select panel of international experts to help develop new evidence-based clinical guidelines used by physicians worldwide for the diagnosis and treatment of blood-clotting disorders, one of the most common cardiovascular diseases in the United States.

Scott M. Stevens, MD, co-director of the Thrombosis Clinic at Intermountain Medical Center, says the new guidelines are critically-needed to ensure that clinicians worldwide are using the most advanced information and protocols available to properly diagnosis deep venous thrombosis, or DVT.

The new guidelines, which will become the global standard of care for the diagnosis of DVT, are published in the February issue of Chest, the journal of the American College of Chest Physicians.

Deep venous thrombosis or DVT mainly affects the large veins in the lower leg and thigh. The clot can block blood flow and cause swelling and pain. When a clot breaks off and moves through the bloodstream, this is called an embolism. An embolism can get stuck in the brain, lungs, heart, or other area, leading to severe damage.

Rapid treatment for DVT is crucial to prevent potentially fatal complications. But the symptoms are often mistaken for a sprain or tendon injury, says Dr. Stevens.

"Thrombosis, particularly DVT, is the third most common cardiovascular disease in the United States, behind only heart attack and stroke," he says. "Prompt treatment is very important to prevent the clot from leaving the leg and traveling to the lungs, heart or brain. Physicians need good information on the best way to diagnose a DVT."

Because of research performed by Dr. Stevens and the team of thrombosis researchers at Intermountain Medical Center, Dr. Stevens was chosen to help draft a new chapter for the ninth edition of the guidelines. Previous editions have not included a chapter on diagnosing DVT.

"This publication is the resource for clinicians seeking evidence-based guidelines for diagnosis, prevention and treatment of thrombosis-related disorders," says Greg Elliott, MD, chair of Department of Medicine at Intermountain Medical Center. "Dr. Stevens earned this recognition by virtue of his excellence as a clinician investigator. His work will result in better care for patients here in Utah and around the world."

Dr. Stevens says the new chapter provides a road map for the best-proven and most cost-effective ways to diagnose DVT.

The process is complicated and involves sophisticated algorithms. Physicians may have difficulty performing those kinds of complex calculations in their day-to-day practice, so the guidelines teach them to use "decision trees" that lead them to accurate diagnoses by asking strategic questions.

Physicians from around the globe everyone from primary care doctors to cardiologists, pulmonologists, orthopedic surgeons, and neurologists will learn from the new guidelines at conferences, seminars, and journals in the coming months.

Dr. Stevens was joined in writing the chapter on DVT diagnosis by 11 other experts from hospitals and universities in Canada, England, Boston, and Buffalo, N.Y. Other chapters of the guidelines, written by different panels, examine the best treatment options for DVT and other blood-clotting disorders.


'/>"/>
Contact: Jess C. Gomez
jess.gomez@imail.org
801-507-7455
Intermountain Medical Center
Source:Eurekalert

Related biology news :

1. Guidelines urge physical activity during pregnancy
2. The International Society for Stem Cell Research releases new guidelines
3. Publication sets guidelines across cancer therapies: Ensuring the best in patient management
4. Coral Disease Handbook: Guidelines for Assessment, Monitoring and Management
5. First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal
6. Report updates guidelines on how much weight women should gain during pregnancy
7. New guidelines to fight obesity in pregnancy issued
8. Following the dietary guidelines may slow heart disease in women
9. Journal of Vascular and Interventional Radiology: New patient radiation safety guidelines
10. LSUHSCs England plays key role in developing new ALS treatment guidelines
11. Pediatrics GI recommendations -- first step to guidelines for children with autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: